Counseling women and men regarding exposures to reproductive and developmental toxicants before conception or women during pregnancy

被引:4
作者
Brent, Robert L. [1 ]
机构
[1] Thomas Jefferson Univ, Alfred I duPont Hosp Children, Wilmington, DE 19899 USA
关键词
Birth defects; Counseling; Development; Environmental toxicants; Pregnancy; Teratology principles; CHILDHOOD-CANCER SURVIVORS; LONG-TERM SURVIVORS; IONIZING-RADIATION; CONGENITAL-MALFORMATIONS; ELECTROMAGNETIC-FIELDS; HUMAN TERATOGENICITY; FEMALE SURVIVORS; EXPERT WITNESS; OUTCOMES; RISK;
D O I
10.1016/j.siny.2013.09.008
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
It should be apparent that determining the reproductive risks of an exposure during pregnancy or the cause of a child's congenital malformations is not a simple process. It involves a careful analysis of the medical and scientific literature pertaining to the reproductive toxic effects of exogenous agents in humans and animals, as well as an evaluation of the exposure and the biological plausibility of the concern of an increased risk or a causal connection between the exposure and a child's congenital malformations. It also involves having available a detailed physical examination of the malformed infant or child and a review of the scientific literature pertaining to genetic and environmental causes of the malformations in question. Abridged counseling on the basis of superficial and incomplete analyses is a disservice to the family. Experienced counselors understand that their primary task is to educate the pregnant women or family members concerning the risk of an environmental exposure. The counselor should advise them on the options available, but not on which option to select. (C) 2013 Elsevier Ltd. All rights reserved..
引用
收藏
页码:139 / 152
页数:14
相关论文
共 91 条
[1]  
Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3<253::AID-AJMG1>3.0.CO
[2]  
2-S
[3]  
American Academy of Pediatrics Center for Child Health Research and the Environmental Protection Agency, 2004, PEDIATRICS S, V113, P933
[4]  
Aurengo A, 2005, DOSE EFFECT RELATION
[5]  
Bellinger DC, 2004, PEDIATRICS, V113, P1016
[6]  
Boice JDJ., 2006, Cancer Epidemiology and Prevention, P259
[7]  
Brent RI., 1976, DHEW PUBLICATION, P379
[8]  
Brent RL, 1999, TERATOLOGY, V59, P261
[9]   Nongenital malformations following exposure to progestational drugs: The last chapter of an erroneous allegation [J].
Brent, RL .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2005, 73 (11) :906-918
[10]  
BRENT RL, 1982, PEDIATRICS, V70, P754